Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.00
Bid: 165.00
Ask: 175.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.061%)
Open: 170.00
High: 170.00
Low: 170.00
Prev. Close: 170.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM, TVR and Directors' Participation

13 Dec 2022 11:29

RNS Number : 5586J
Helios Underwriting Plc
13 December 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

13 December 2022

 

Helios Underwriting plc

("Helios" or the "Company")

 

Result of General Meeting

Total Voting Rights

and

Directors' Participation

 

Result of General Meeting

 

Further to its announcements of 23 November, 24 November and 12 December 2022 (the "Announcements"), Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, is pleased to announce that each of the Resolutions put to Shareholders at the General Meeting held earlier today were duly passed.

 

Application has therefore been made for, in aggregate, 8,196,195 New Ordinary Shares to be admitted to trading on AIM, comprising 7,843,927 Placing Shares, 200,000 Subscription Shares and the 152,268 Open Offer Shares for which valid applications were received under the Open Offer. Admission is expected to occur at 8.00 am on 14 December 2022. 

 

Total Voting Rights

Following Admission, the Company will have 77,082,407 Ordinary Shares in issue admitted to trading on AIM (excluding the 419,169 Ordinary Shares held in treasury and which do not carry voting rights). This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Directors' Participation

The Directors' resulting shareholdings immediately following Admission are detailed below:

 

 

At the Latest Practicable Date

Participation in the Placing or Subscription

Participation in Open Offer

Immediately following Admission

Name

Number of Ordinary Shares

Percentage of Existing Ordinary Shares

Number of Placing Shares or Subscription Shares

Number of Open Offer Shares

Number of Ordinary Shares

Percentage of Enlarged Share Capital

Michael Cunningham

86,848

0.13%

200,000

-

286,848

0.37%

Nigel Hanbury*

9,549,794

13.86%

12,564

-

9,562,358

12.41%

Arthur Manners**

1,187,368

1.72%

-

10,141

1,197,509

1.55%

Andrew Christie

34,317

0.05%

-

234

34,551

0.04%

Edward Fitzalan-Howard

382,864

0.56%

-

-

382,864

0.50%

Martin Reith

130,161

0.19%

127,566

-

257,727

0.33%

Tom Libassi***

13,407,000

19.46%

-

-

13,407,000

17.39%

 

* 622,500 of Nigel Hanbury's Ordinary Shares are jointly owned in accordance with the Company's Joint Share Ownership Plan - 300,000 of which are detailed in the announcement made by the Company on 14 December 2017 and 322,500 of which are detailed in the announcement made by the Company on 17 August 2021.

** 477,500 of Arthur Manner's shares are jointly owned in accordance with the Company's Joint Share Ownership Plan, 200,000 of which are detailed in the announcement made by the Company on 14 December 2017 and 277,500 of which are detailed in the announcement made by the Company on 17 August 2021.

*** Tom Libassi does not hold Ordinary Shares in the Company but is the Co-founder and Managing Partner of Resolute Global Partners Limited, which funds under management of, or associated with, holds 13,407,000 Ordinary Shares.

 

This announcement should be read in conjunction with the Announcements and the full text of the Company's circular dated 24 November 2022 ("Circular"), copies of which are available on the Company's website at www.huwplc.com. Capitalised terms in this announcement have the same meaning as given in the Circular.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

 

Gallagher (Financial Adviser) +44 (0)20 3124 6033

Deepon Sen Gupta

Alastair Rodger

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £232 million of underwriting capacity for the 2022 year of account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFXLFFLLLLFBZ
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.